Published in Toxicon on January 01, 1990
Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells. Infect Immun (2013) 0.83
Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin. Infect Immun (1992) 0.75
Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology (2010) 3.40
Transport route for synaptobrevin via a novel pathway of insertion into the endoplasmic reticulum membrane. EMBO J (1995) 2.96
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology (2012) 2.78
125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.92
Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences. Exp Neurol (1997) 1.61
Minimal requirements for exocytosis. A study using PC 12 cells permeabilized with staphylococcal alpha-toxin. J Biol Chem (1985) 1.40
Characterization of hormone and protein release from alpha-toxin-permeabilized chromaffin cells in primary culture. J Biol Chem (1986) 1.38
Expression of Kv1 potassium channels in mouse hippocampal primary cultures: development and activity-dependent regulation. J Neurosci (2000) 1.24
Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech Dev (1995) 1.24
The synaptophysin-synaptobrevin complex: a hallmark of synaptic vesicle maturation. J Neurosci (1999) 1.20
A long-term follow-up of botulinum toxin A in cervical dystonia. Neurol Res (2009) 1.17
Characterization of the inositol 1,4,5-trisphosphate-induced calcium release from permeabilized endocrine cells and its inhibition by decavanadate and p-hydroxymercuribenzoate. Biochem J (1989) 1.11
Plasticity of rat central inhibitory synapses through GABA metabolism. J Physiol (2001) 1.10
Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem (2005) 1.09
Purification of alpha-toxin from Staphylococcus aureus and application to cell permeabilization. Anal Biochem (1987) 1.07
Botulinum and tetanus neurotoxins: emerging tools for the study of membrane fusion. Cold Spring Harb Symp Quant Biol (1995) 1.04
Loss of beta1 integrin function results in a retardation of myogenic, but an acceleration of neuronal, differentiation of embryonic stem cells in vitro. Dev Biol (1998) 1.04
A heterotrimeric G protein of the Gi family is required for cAMP-triggered trafficking of aquaporin 2 in kidney epithelial cells. J Biol Chem (1998) 1.04
Potential roles of heterotrimeric G proteins of the endomembrane system. FEBS Lett (1996) 1.01
Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.99
Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.99
Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.98
Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol (2006) 0.97
Voltage clamp studies on the stretch response in the neuron of the slowly adapting crayfish stretch receptor. Pflugers Arch (1973) 0.97
Intraaxonal and extraaxonal transport of 125I-tetanus toxin in early local tetanus. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.97
Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. J Neurophysiol (1987) 0.96
Monoclonal antibodies against tetanus toxin and toxoid. Med Microbiol Immunol (1983) 0.95
The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2). J Neurosci (2000) 0.94
High-performance liquid chromatographic assay for the measurement of azathioprine in human serum samples. J Chromatogr B Biomed Appl (1996) 0.93
Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture. Brain Res (1985) 0.91
The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.91
Molecular aspects of tetanus and botulinum neurotoxin poisoning. Prog Neurobiol (1995) 0.90
IgA protease from Neisseria gonorrhoeae inhibits exocytosis in bovine chromaffin cells like tetanus toxin. J Biol Chem (1995) 0.90
Palytoxin both induces and inhibits the release of histamine from rat mast cells. Int Arch Allergy Appl Immunol (1982) 0.89
Expression of functional GABAA receptors in neuroendocrine gastropancreatic cells. Pflugers Arch (1995) 0.89
Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure. Toxicon (1986) 0.88
Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.88
Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay. Mov Disord (2000) 0.88
A T cell receptor-associated GTP-binding protein triggers T cell receptor-mediated granule exocytosis in cytotoxic T lymphocytes. J Immunol (1988) 0.87
Inactivation of a T cell receptor-associated GTP-binding protein by antibody-induced modulation of the T cell receptor/CD3 complex. J Exp Med (1988) 0.87
Spermidine synthase is prominently expressed in the striatal patch compartment and in putative interneurones of the matrix compartment. J Neurochem (2006) 0.87
Tetanus toxin in dissociated spinal cord cultures: long-term characterization of form and action. J Neurochem (1986) 0.87
The synaptophysin-synaptobrevin complex is developmentally upregulated in cultivated neurons but is absent in neuroendocrine cells. Eur J Cell Biol (1999) 0.86
Slow changes of membrane permeability in giant neurones of Helix pomatia. Pflugers Arch (1971) 0.86
Botulinum neurotoxin - from laboratory to bedside. Neurotox Res (2006) 0.86
The light chain but not the heavy chain of botulinum A toxin inhibits exocytosis from permeabilized adrenal chromaffin cells. FEBS Lett (1989) 0.86
Botulism type B presenting as pure autonomic dysfunction. Clin Auton Res (2003) 0.85
Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.85
Controlled manipulation of the cell interior by pore-forming proteins. Trends Pharmacol Sci (1988) 0.85
Synaptobrevin 2 is palmitoylated in synaptic vesicles prepared from adult, but not from embryonic brain. Mol Cell Neurosci (2000) 0.85
Toxicokinetics of labeled amatoxins in the dog. Arch Toxicol (1985) 0.85
Inhibition of voltage-dependent Ca2+ channels via alpha 2-adrenergic and opioid receptors in cultured bovine adrenal chromaffin cells. Pflugers Arch (1992) 0.85
Guanylin stimulates regulated secretion from human neuroendocrine pancreatic cells. Gastroenterology (1998) 0.84
Electrophysiological properties of human carcinoid cells of the gut. Gastroenterology (1997) 0.84
Release of vasopressin from isolated permeabilized neurosecretory nerve terminals is blocked by the light chain of botulinum A toxin. Neuroscience (1990) 0.84
The light chain of tetanus toxin inhibits calcium-dependent vasopressin release from permeabilized nerve endings. Neuroscience (1992) 0.84
Reductive chain separation of botulinum A toxin--a prerequisite to its inhibitory action on exocytosis in chromaffin cells. FEBS Lett (1989) 0.83
Differential distribution of voltage-gated potassium channels Kv 1.1-Kv1.6 in the rat retina during development. J Neurosci Res (2007) 0.83
Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin. Biochem J (1992) 0.82
Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system. J Mol Med (Berl) (1998) 0.82
Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells. Toxicon (1989) 0.82
Tetanus toxin: inhibitory action in chromaffin cells is initiated by specified types of gangliosides and promoted in low ionic strength solution. Neurosci Lett (1989) 0.82
The reflex influence of a group of slowly conducting vagal afferents on alpha and gamma discharges in cat intercostal nerves. Pflugers Arch (1970) 0.82
Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells. Life Sci (2002) 0.81
Serotonin uptake and release mechanisms in developing cultures of rat embryonic raphe neurons: age- and region-specific differences. Neuroscience (2000) 0.81
False-positive EMIT indication of opiates and methadone in a doxylamine intoxication. J Clin Chem Clin Biochem (1983) 0.81
Tetanus and botulinum A toxins inhibit stimulated F-actin rearrangement in chromaffin cells. Neuroreport (1991) 0.81
Local tetanus in cats: the influence of neuromuscular activity on spinal distribution of 125 I labelled tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.81
Activity-dependent changes of the presynaptic synaptophysin-synaptobrevin complex in adult rat brain. Eur J Cell Biol (2001) 0.81
Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy. Neuropediatrics (2000) 0.81
Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.81
Further characterization of dopamine release by permeabilized PC12 cells. J Neurochem (1987) 0.80
The effect of veratridine on Helix pomatia neurones. Pflugers Arch (1971) 0.80
GTP and Ca2+ modulate the inositol 1,4,5-trisphosphate-dependent Ca2+ release in streptolysin O-permeabilized bovine adrenal chromaffin cells. J Neurochem (1991) 0.80
Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.80
Inhibition of synaptosomal choline uptake by tetanus and botulinum A toxin. Partial dissociation of fixation and effect of tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.80
Differential distribution of G-protein beta-subunits in brain: an immunocytochemical analysis. Eur J Cell Biol (1999) 0.80
Regulation of vesicular monoamine and glutamate transporters by vesicle-associated trimeric G proteins: new jobs for long-known signal transduction molecules. Handb Exp Pharmacol (2006) 0.80
Qualitative and quantitative analysis of synapses in Hirschsprung's disease. Pediatr Surg Int (1998) 0.80
Delayed haemolytic action of palytoxin. General characteristics. Biochim Biophys Acta (1981) 0.80
Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin. J Neurol Neurosurg Psychiatry (1998) 0.79
[Molecules of regulated secretion are differentiation markers of neuroendocrine tumors]. Verh Dtsch Ges Pathol (1997) 0.79
Electrical excitability of motoneurones in early local tetanus. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.79
Results of a BoNT/A antibody study in children and adolescents after onabotulinumtoxin A (Botox®) detrusor injection. Urol Int (2011) 0.79
Intraspinal distribution and reaction in the grey matter with tetanus toxin of intracisternally injected anti-tetanus toxoid F(ab')2 fragments. Brain Res (1981) 0.79
SAP 97 is a potential candidate for basolateral fixation of ezrin in parietal cells. Histochem Cell Biol (1999) 0.79
Changes in erythrocyte permeability due to palytoxin as compared to amphotericin B. Biochim Biophys Acta (1982) 0.79
Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.78
Advances in tetanus research. Klin Wochenschr (1974) 0.78
Uptake of antitetanus F(ab')2 fragments into eukaryotic cells. J Physiol (Paris) (1990) 0.78
Liposome-entrapped [125I]anti-tetanus immunoglobulin G: evidence for entry into spinal cord neurons of the rat. Neurosci Lett (1984) 0.78
The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humans. J Neurol (2000) 0.78
Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Eur Neurol (2000) 0.78
Specific antibodies against the Zn(2+)-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin. J Biol Chem (1994) 0.78
Investigations of thermotropic phase changes in peripheral nerve of frog and rat. A spin label study. Biochim Biophys Acta (1975) 0.78
Kinetics of [3H]acetylcholine synthesis and release in primary cell cultures from mammalian CNS. J Neurochem (1978) 0.77
Tetanus toxin and botulinum A toxin inhibit acetylcholine release from but not calcium uptake into brain tissue. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77
The translocation of botulinum A neurotoxin by chromaffin cells is promoted in low ionic strength solution and is insensitive to trypsin. Toxicon (1991) 0.77
Microelectrode measurement of cell membrane potential in isolated hepatocytes attached to collagen. Biochim Biophys Acta (1986) 0.77